Showing results (1731-1740 of 1,814) with videos related to
Sort By:
Pageof 182
European Journal of Cancer (Oxford, England : 1990)|January 7, 2022
Second-line treatment after docetaxel, cisplatin and 5-fluorouracil in metastatic squamous cell carcinomas of the anus. Pooled analysis of prospective Epitopes-HPV01 and Epitopes-HPV02 studiesMorgane Stouvenot, Aurélia Meurisse, Angélique Saint, et al.Molecular Psychiatry|May 14, 2020
Epigenome-wide association study and multi-tissue replication of individuals with alcohol use disorder: evidence for abnormal glucocorticoid signaling pathway gene regulationFalk W Lohoff, Arunima Roy, Jeesun Jung, et al.Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|November 10, 2018
Vaccination Against Influenza in Pregnancy: A Survey of Canadian Maternity Care ProvidersEve Dubé, Dominique Gagnon, Kyla Kaminsky, et al.Current Problems in Cardiology|March 31, 2021
Current Activities Centered on Healthy Living and Recommendations for the Future: A Position Statement from the HL-PIVOT NetworkRoss Arena, Jonathan Myers, Leonard A Kaminsky, et al.The Lancet. Oncology|July 26, 2018
Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 studyStefano Kim, Eric François, Thierry André, et al.Nature Communications|January 6, 2026
Neoadjuvant immune checkpoint blockade before chemoradiation for cervical squamous carcinoma (GINECO window-of-opportunity COLIBRI study): a phase II trialIsabelle Ray-Coquard, Marie-Christine Kaminsky-Forrett, Ryotaro Ohkuma, et al.JCO Precision Oncology|January 14, 2026
Early Clinical and Molecular Biomarkers in Patients With Advanced Ovarian Cancer Undergoing Neoadjuvant Chemotherapy: CHIVA Phase II GINECO TrialFélix Blanc-Durand, Benoit You, Yahia Adnani, et al.Journal of Neurology|March 2, 2026
Electrophysiological assessment of motor unit loss in adult spinal muscular atrophy types III and IV: a multicenter national study comparing MUNIX, CMAP, and MUSIXEva Sole-Cruz, Emmanuelle Salort-Campana, Timothee Lenglet, et al.Mayo Clinic Proceedings|July 7, 2015
Healthy Lifestyle Interventions to Combat Noncommunicable Disease—A Novel Nonhierarchical Connectivity Model for Key Stakeholders: A Policy Statement From the American Heart Association, European Society of Cardiology, European Association for Cardiovascular Prevention and Rehabilitation, and American College of Preventive MedicineRoss Arena, Marco Guazzi, Liana Lianov, et al.Orphanet Journal of Rare Diseases|October 11, 2012
The French Gaucher's disease registry: clinical characteristics, complications and treatment of 562 patientsJérôme Stirnemann, Marie Vigan, Dalil Hamroun, et al.Pageof 182